Custom Search

Brand Name(s): Fosamax

CAS nº: 121268-17-5

(a-LEN-dro-nate)

What is Alendronate?

Alendronate is in a class of medications used to strengthen the bone. A young bone is in a constant state of remodeling and is composed by cells called osteoblasts, whereby old bone is removed by cells called osteoclasts. Alendronate inhibits bone removal by the osteoclasts.

This medication is primarily used to treat osteoporosis (thinning of bone) in women after menopause. After menopause, there is an increased rate of bone loss (resorption). In these patients, alendronate has been shown to increase bone density while strengthening it at the same time, and decrease the rate of bone fractures.

Alendronate is also helpful in the treatment of Paget's disease of the bone. Paget's disease is characterized by a disorderly and accelerated remodeling of the bone, leading to bone weakness and pain.

See more Product Info

Latest News

Amgen says denosumab improves bone vs Fosamax

Amgen Inc said on Monday a trial of its experimental osteoporosis drug, denosumab, showed it...

[more]

Wal-Mart Expands Prescription Program for Generics

Wal-Mart says it will sell discounted 90-day supplies of up to 350 generic products as the third...

[more]

Alendronate warning on atrial fibrillation

A drug commonly used to treat osteoporosis in women could increase atrial fibrillation (AF) risk...

[more]

Teva Announces Two Court Decisions to Revoke MSD's European Patent on Generic Fosamax®

Teva Pharmaceutical Industries Ltd. (Ticker: TEVA) announced the following decisions by two...

[more]

Generic Fosamax Approved

The U.S. Food and Drug Administration approved the first generic versions of Fosamax (alendronate...

[more]

Use of this site is subject to the following terms of use